共 50 条
- [41] From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid [J]. SCIENTIFIC REPORTS, 2016, 6
- [42] Effects of Intranasal Orexin-A (Hypocretin-1) Administration on Neuronal Activation, Neurochemistry, and Attention in Aged Rats [J]. FRONTIERS IN AGING NEUROSCIENCE, 2020, 11
- [44] From radioimmunoassay to mass spectrometry: a new method to quantify orexin-A (hypocretin-1) in cerebrospinal fluid [J]. Scientific Reports, 6
- [45] Developmental changes in CSF hypocretin-1 (orexin-A) levels in normal and genetically narcoleptic Doberman pinschers [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2004, 560 (02): : 587 - 592
- [46] Misdiagnosis of narcolepsy caused by a false-positive orexin-A/hypocretin-1 enzyme immune assay [J]. JOURNAL OF CLINICAL SLEEP MEDICINE, 2022, 18 (08): : 2075 - 2078
- [47] Low CSF hypocretin-1/orexin-A associated with hypersomnia secondary to hypothalamic lesion in a case of multiple sclerosis [J]. Journal of Neurology, 2004, 251 : 885 - 886
- [48] Decreased hypocretin-1 (Orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness [J]. SLEEP, 2003, 26 (03): : 287 - 290
- [49] CSF hypocretin-1 (orexin-A) concentration of patients with Niemann-Pick type C disease. [J]. SLEEP, 2002, 25 : A376 - A377